Download App

Log in to access Online Inquiry
Company Overview More
Genting Xinyao Co., Ltd. is a company mainly engaged in the licensing, clinical development and commercialization of therapy to address unmet medical needs. The company has been focused on the development of innovative drug candidates. The company has developed a promising portfolio of clinical drug candidates covering oncology, immunology, heart and kidney diseases and infectious diseases. The company mainly provides products and services in Greater China and other emerging markets in the Asia-Pacific region.
CEO: Wei Fu
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > 01952 EVEREST MED-B > Detailed Quotes

01952 EVEREST MED-B

21.800-0.650-2.90%
Closed 05/19 16:08 CCT
High
22.850
Open
21.750
Turnover
31.79M
Low
21.150
Pre Close
22.450
Volume
1.46M
Market Cap
6.57B
P/E(TTM)
Loss
52wk High
79.900
Shares
301.22M
P/E(Static)
Loss
52wk Low
13.860
Float Cap
6.57B
Bid/Ask %
45.58%
Historical High
104.800
Shs Float
301.22M
Volume Ratio
1.02
Historical Low
13.860
Dividend TTM
--
Div Yield TTM
--
P/B
0.91
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.49%
Amplitude
7.57%
Avg Price
21.712
Lot Size
500
Float Cap
6.57B
Bid/Ask %
45.58%
Historical High
104.800
Shs Float
301.22M
Volume Ratio
1.02
Historical Low
13.860
Dividend TTM
--
P/B
0.91
Dividend LFY
--
Turnover Ratio
0.49%
Amplitude
7.57%
Avg Price
21.712
Lot Size
500
Price Forecast

No Data

News

Comment

No More